The Roles of CD4+T Cells in Tumor Immunity

Author:

Lai Yo-Ping1,Jeng Chung-Jiuan2,Chen Shu-Ching3

Affiliation:

1. Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, Taiwan

2. Institute of Anatomy and Cell Biology, School of Medicine, National Yang-Ming University, Taipei 122, Taiwan

3. Department of Medical Research, National Taiwan University Hospital, Taipei 100, Taiwan

Abstract

Activation of CD8+cytotoxic T cells has long been regarded as a major antitumor mechanism of the immune system. Emerging evidence suggests that CD4+T cells are required for the generation and maintenance of effective CD8+cytotoxic and memory T cells, a phenomenon known as CD4+T-cell help. CD4+T-cell help facilitates the optimal expansion, trafficking, and effector function of CD8+T cells, thereby enhancing tumor destruction. In addition, a specialized subset of CD4+T cells, CD4+CD25+regulatory T cells (TRegs), effectively hampers anti-tumor immune responses, which has been proposed to be one of the major tumor immune evasion mechanisms. Here, we review recent advances in deciphering how anti-tumor immune responses are orchestrated by CD4+T cells. We will also discuss the immunotherapeutic potential of CD4+T-cell manipulation in anti-tumor immune response.

Funder

National Science Council

Publisher

Hindawi Limited

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3